US Physical Therapy Inc. buy JPMorgan Chase & Co.
Start price
18.03.24
/
50%
€98.00
Target price
18.03.25
€107.59
Performance (%)
-23.67%
Price
22.08.24
€74.00
Summary
This prediction is currently active. The prediction for US Physical Therapy Inc. disappoints with a performance of -23.67%. Dividends of €0.80 are taken into consideration when calculating the performance. This prediction currently runs until 18.03.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
US Physical Therapy Inc. | -1.333% | -1.333% |
iShares Core DAX® | 1.665% | 0.362% |
iShares Nasdaq 100 | -0.475% | -3.195% |
iShares Nikkei 225® | 2.620% | 1.174% |
iShares S&P 500 | -0.091% | -1.597% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread US Physical Therapy Inc. diskutieren
U.S. Physical Therapy, Inc. (NYSE: USPH) had its price target raised by analysts at JPMorgan Chase & Co. from $99.00 to $117.00. They now have an "overweight" rating on the stock.
Ratings data for USPH provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for US Physical Therapy Inc.
US Physical Therapy Inc.
Start price
Target price
Perf. (%)
€77.50
17.11.23
17.11.23
€90.95
17.11.24
17.11.24
-2.97%
22.08.24
22.08.24